◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

APPLIED BIOSCIENCES CORP.

CIK: 1607549 SIC: 2040
$859.86K
Revenue
$-3.06M
Net Income
61.44%
Gross Margin
-311.94%
Op. Margin
$-2.10M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 5 annual reports available (2014 - 2018)
Breakdown TTM
(Dec 31, 2019)
FY 2018
(Mar 31, 2019)
FY 2017
(Mar 31, 2018)
FY 2016
(Mar 31, 2017)
FY 2015
(Mar 31, 2016)
FY 2014
(Mar 31, 2015)
+ Total Revenue $859.86K $707.06K $197.55K $45.55K - -
Revenue Growth % 21.6% 257.9% 333.7% nan% nan% nan%
Cost of Revenue $331.55K $521.77K $155.55K $6.39K - -
+ Gross Profit $528.31K $185.29K $42.01K $39.16K - -
Gross Margin % 61.4% 26.2% 21.3% 86.0% nan% nan%
Operating Expenses $3.21M $2.83M $2.43M $555.08K $28.45K $16.67K
+ Operating Income $-2.68M $-2.65M $-2.39M - - -
Operating Margin % -311.9% -374.3% -1208.2% nan% nan% nan%
Interest Expense $-79.82K $648.88K - - - -
Other Income/Expense $-378.78K $-32.72K - - - -
+ Net Income $-3.06M $-2.68M $-2.39M $-515.92K $-28.45K $-16.67K
Net Margin % -356.0% -378.9% -1208.2% -1132.5% nan% nan%
Breakdown FY 2018
(Mar 31, 2019)
FY 2017
(Mar 31, 2018)
FY 2016
(Mar 31, 2017)
FY 2015
(Mar 31, 2016)
FY 2014
(Mar 31, 2015)
Cash & Cash Equivalents $47.04K $60.93K $212.64K $2.19K -
Accounts Receivable $163.41K $12.39K $5.68K - -
Inventory $78.74K $29.07K $22.70K - -
Total Current Assets $354.46K $226.85K $257.93K $2.19K -
Property Plant & Equipment $452.05K $4.44K - - -
Goodwill $1.94M - - - -
Intangible Assets - - $1.12M - -
Other Non-current Assets $5.50K $5.50K - - -
Total Assets $3.65M $705.33K $1.68M - -
Accounts Payable $278.55K $21.85K $12.30K $263.00 $2.07K
Total Current Liabilities $374.27K $35.88K $31.58K $41.04K $13.49K
Common Stock $135.00 $105.00 $152.00 $100.04K $2.59M
Retained Earnings $-5.53M $-2.90M $-525.83K $-46.94K $-18.49K
Total Stockholders Equity $2.13M $669.44K $1.64M $-38.85K $-13.49K
Total Liabilities & Equity $3.65M $705.33K $1.68M $2.19K -
Breakdown TTM
(Dec 31, 2019)
FY 2018
(Mar 31, 2019)
FY 2017
(Mar 31, 2018)
FY 2016
(Mar 31, 2017)
FY 2015
(Mar 31, 2016)
FY 2014
(Mar 31, 2015)
Net Income $-4.93M $-2.68M $-2.39M $-515.92K $-28.45K $-16.67K
Depreciation & Amortization $199.82K $40.63K $224.77K $19.96K - -
Change in Receivables $178.41K $-23.02K $-6.71K $-5.68K - -
Change in Inventory $-94.96K $-49.66K $-6.38K $-16.83K - -
Change in Payables - - - - $-1.81K $2.07K
Operating Cash Flow $-2.10M $-905.05K $-673.47K $-150.84K $-30.25K $-14.60K
Capital Expenditure - $1.55K $4.70K - - -
Purchases of Investments - - $168.54K $300.00K - -
Investing Cash Flow - $-713.29K $-173.24K $-775.00K - -
Stock Issued - $75.00K $795.00K $1.13M $3.09K -
Financing Cash Flow $2.06M $1.60M $695.00K $1.14M $32.44K $9.60K
Net Change in Cash $-203.04K $-13.89K $-151.70K $212.64K - -
SEC Filing Format - Data shown as it appears in the Q3 2020 (10-Q) filing Period ended: Dec 31, 2019
Condensed Consolidated Statements of Operations
Description Dec 31, 2019 Dec 31, 2019
Current Prior Year Current YTD Prior Year YTD
Total Revenue $169.57K - $625.31K -
Cost of Revenue $51.34K - $249.51K -
Gross Profit $118.23K - $375.79K -
Operating Expenses $1.09M - $2.65M -
Operating Income $-970.24K - $-2.27M -
Interest Expense $-89.02K - $-153.82K -
Other Income/Expense $-455.63K - $-516.18K -
Net Income $-1.43M $-113.76K $-2.79M -
Condensed Consolidated Balance Sheets
Description Dec 31, 2019 Mar 31, 2019
Cash & Cash Equivalents $21.27K $47.04K
Accounts Receivable $76.20K $163.41K
Inventory $101.52K $78.74K
Other Current Assets $14.67K $65.27K
Total Current Assets $213.66K $354.46K
Goodwill $1.94M $1.94M
Other Non-current Assets $10.13K $5.50K
Total Assets $3.42M $3.65M
Accounts Payable $659.68K $278.55K
Total Current Liabilities $2.02M $374.27K
Total Liabilities $2.28M $374.27K
Common Stock $143.00 $135.00
Retained Earnings $-8.09M $-5.53M
Total Stockholders Equity $1.14M $3.28M
Total Liabilities & Equity $3.42M $3.65M
Condensed Consolidated Statements of Cash Flows
Description Dec 31, 2019 Dec 31, 2019
Current Prior Year Current YTD Prior Year YTD
Net Income $-1.43M $-113.76K $-2.79M -
Depreciation & Amortization $40.83K - $120.32K -
Change in Receivables - - $53.75K -
Change in Inventory - - $-22.79K -
Operating Cash Flow - - $-817.72K -
Investing Cash Flow - - - -
Stock Issued - - - -
Financing Cash Flow - - $791.94K -
Net Change in Cash - - $-25.78K -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...